These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8437240)

  • 61. The SIVmac specific cytotoxic T lymphocyte response in the acutely infected rhesus monkey.
    Letvin NL; Reimann KA; Yasutomi Y; Ringler DJ; Yamamoto H
    Curr Top Microbiol Immunol; 1994; 188():175-84. PubMed ID: 7924426
    [No Abstract]   [Full Text] [Related]  

  • 62. The simian immunodeficiency virus deltaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response.
    Stahl-Hennig C; Steinman RM; Ten Haaft P; Uberla K; Stolte N; Saeland S; Tenner-Racz K; Racz P
    J Virol; 2002 Jan; 76(2):688-96. PubMed ID: 11752159
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dynamics of the immune system response in cerebrospinal fluid and blood of SIVmac-infected rhesus monkeys.
    Sopper S; Hemm S; Meixensberger J; Coulibaly C; Stahl-Hennig C; Hunsmann G; Fleckenstein B; ter Meulen V; Dörries R
    J Med Primatol; 1993; 22(2-3):138-46. PubMed ID: 8411105
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.
    Ansari AA; Mayne AE; Sundstrom JB; Bostik P; Grimm B; Altman JD; Villinger F
    J Virol; 2002 Feb; 76(4):1731-43. PubMed ID: 11799168
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.
    Metzner KJ; Moretto WJ; Donahoe SM; Jin X; Gettie A; Montefiori DC; Marx PA; Binley JM; Nixon DF; Connor RI
    J Gen Virol; 2005 Dec; 86(Pt 12):3375-3384. PubMed ID: 16298985
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of adaptive Vgamma2Vdelta2+ T-cell responses during active mycobacterial coinfection of simian immunodeficiency virus SIVmac-infected monkeys.
    Zhou D; Lai X; Shen Y; Sehgal P; Shen L; Simon M; Qiu L; Huang D; Du GZ; Wang Q; Letvin NL; Chen ZW
    J Virol; 2003 Mar; 77(5):2998-3006. PubMed ID: 12584325
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.
    McChesney MB; Collins JR; Lu D; Lu X; Torten J; Ashley RL; Cloyd MW; Miller CJ
    J Virol; 1998 Dec; 72(12):10029-35. PubMed ID: 9811741
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Voss G; Li J; Manson K; Wyand M; Sodroski J; Letvin NL
    Virology; 1995 Apr; 208(2):770-5. PubMed ID: 7747449
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Early Env-specific CTLs effectively suppress viral replication in SHIV controller macaques.
    Fan J; Liang H; Shen T; Wang S; Ji X; Yee C; Lu F; Shao Y
    Cell Immunol; 2018 Sep; 331():30-37. PubMed ID: 29773224
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A simian immunodeficiency virus envelope V3 cytotoxic T-lymphocyte epitope in rhesus monkeys and its restricting major histocompatibility complex class I molecule Mamu-A*02.
    Watanabe N; McAdam SN; Boyson JE; Piekarczyk MS; Yasutomi Y; Watkins DI; Letvin NL
    J Virol; 1994 Oct; 68(10):6690-6. PubMed ID: 7521921
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys.
    Watanabe N; Sypek JP; Mittler S; Reimann KA; Flores-Villanueva P; Voss G; Lord CI; Letvin NL
    AIDS Res Hum Retroviruses; 1998 Mar; 14(5):393-9. PubMed ID: 9546798
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vivo administration of CD4-specific monoclonal antibody: effect on provirus load in rhesus monkeys chronically infected with the simian immunodeficiency virus of macaques.
    Reimann KA; Cate RL; Wu Y; Palmer L; Olson D; Waite BC; Letvin NL; Burkly LC
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):517-25. PubMed ID: 7632466
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vivo T-lymphocyte activation and transient reduction of viral replication in macaques infected with simian immunodeficiency virus.
    Chen ZW; Shen Y; Zhou D; Simon M; Kou Z; Lee-Parritz D; Shen L; Sehgal P; Letvin NL
    J Virol; 2001 May; 75(10):4713-20. PubMed ID: 11312343
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An activated CD8+ lymphocyte appears in lymph nodes of rhesus monkeys early after infection with simian immunodeficiency virus.
    Reimann KA; Snyder GB; Chalifoux LV; Waite BC; Miller MD; Yamamoto H; Spertini O; Letvin NL
    J Clin Invest; 1991 Oct; 88(4):1113-20. PubMed ID: 1717508
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.
    Tsubota H; Lord CI; Watkins DI; Morimoto C; Letvin NL
    J Exp Med; 1989 Apr; 169(4):1421-34. PubMed ID: 2784486
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5).
    Hulskotte EG; Geretti AM; Siebelink KH; van Amerongen G; Cranage MP; Rud EW; Norley SG; de Vries P; Osterhaus AD
    J Virol; 1995 Oct; 69(10):6289-96. PubMed ID: 7666529
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus.
    Smith MO; Heyes MP; Lackner AA
    Lab Invest; 1995 May; 72(5):547-58. PubMed ID: 7745949
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
    Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
    J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Heterogeneity of the simian immunodeficiency virus (SIV) specific CD8(+) T-cell response in mucosal tissues during SIV primary infection.
    Vingert BC; Le Grand R; Venet A
    Microbes Infect; 2003 Jul; 5(9):757-67. PubMed ID: 12850201
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Detection of simian immunodeficiency virus Gag-specific CD8(+) T lymphocytes in semen of chronically infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex.
    Jordan HL; Kuroda MJ; Schmitz JE; Steenbeke T; Forman MA; Letvin NL
    J Virol; 1999 May; 73(5):4508-12. PubMed ID: 10196357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.